Institutional Ownership Axsome Therapeutics, Inc. (AXSM)
This table provides information about the institutional ownership of Axsome Therapeutics, Inc. (AXSM). We have compiled data on the 414 institutions that hold shares in the stock, with a total of 36.8 Million shares, which have been reported (via 13F filing form) to have a value of $5.14 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
4,180,646
shares
|
$584 Million
0.01% of portfolio
|
Q3 2025
Added 5.97%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,299,991
shares
|
$461 Million
0.01% of portfolio
|
Q2 2024
Added 3.27%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,334,560
shares
|
$186 Million
0.03% of portfolio
|
Q3 2025
Added 84.07%
|
|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,118,883
shares
|
$156 Million
1.82% of portfolio
|
Q3 2025
Reduced 26.24%
|
|
|
Macquarie Group LTD
Australia, C3 |
Nov 13, 2025 Q3 2025 |
1,084,536
shares
|
$151 Million
0.16% of portfolio
|
Q3 2025
Reduced 4.68%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
1,037,448
shares
|
$145 Million
0.01% of portfolio
|
Q3 2025
Added 69.31%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
997,700
shares
|
$139 Million
0.01% of portfolio
|
Q3 2025
Added 0.83%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
990,557
shares
|
$138 Million
0.02% of portfolio
|
Q3 2025
Added 73.31%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
942,960
shares
|
$132 Million
0.0% of portfolio
|
Q3 2025
Reduced 1.62%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
900,000
shares
|
$126 Million
3.45% of portfolio
|
Q3 2025
Added 12.31%
|
|
|
Fairmount Funds Management LLC
Philadelphia, PA |
Nov 14, 2025 Q3 2025 |
815,176
shares
|
$114 Million
21.55% of portfolio
|
Q1 2025
Reduced 44.51%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2025 Q3 2025 |
746,398
shares
|
$104 Million
1.67% of portfolio
|
Q3 2025
Added 2.86%
|
|
|
Alethea Capital Management, LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
670,883
shares
|
$93.7 Million
52.44% of portfolio
|
Q3 2025
Added 0.53%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
531,800
shares
|
$74.3 Million
2.2% of portfolio
|
Q3 2025
Added 24.28%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
530,332
shares
|
$74.1 Million
5.43% of portfolio
|
Q3 2025
Added 9.78%
|
|
|
Bvf Inc
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
486,757
shares
|
$68 Million
3.2% of portfolio
|
Q3 2025
Reduced 71.2%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
463,842
shares
|
$64.8 Million
0.04% of portfolio
|
Q2 2023
Added 13921.83%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
445,000
shares
|
$62.2 Million
0.09% of portfolio
|
Q3 2025
Reduced 0.45%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
409,580
shares
|
$57.2 Million
0.0% of portfolio
|
Q3 2025
Reduced 8.56%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
409,535
shares
|
$57.2 Million
0.01% of portfolio
|
Q3 2025
Added 0.03%
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Nov 13, 2025 Q3 2025 |
393,499
shares
|
$55 Million
2.93% of portfolio
|
Q3 2025
Added 320.36%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
382,047
shares
|
$53.4 Million
0.01% of portfolio
|
Q3 2025
Added 7.12%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
378,024
shares
|
$52.8 Million
0.05% of portfolio
|
Q3 2025
Added 566.52%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Nov 04, 2025 Q3 2025 |
368,434
shares
|
$51.5 Million
0.02% of portfolio
|
Q3 2025
Added 3.64%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 18, 2025 Q3 2025 |
362,138
shares
|
$50.6 Million
0.04% of portfolio
|
Q3 2025
Reduced 12.07%
|
|